Lipo B vs Wegovy — Weight Loss Injection Comparison

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Two injectable therapies dominate the weight loss conversation today: Lipo B formulations and Wegovy (semaglutide). Both leverage the same active compound—semaglutide—to reduce appetite and improve metabolic control, yet they differ significantly in formulation, cost, and accessibility. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, giving patients a transparent alternative to branded options.

What Is Lipo B and How Does It Work for Weight Loss?

Lipo B refers to lipotropic injection formulations that traditionally combined B vitamins with amino acids like methionine, inositol, and choline (MIC injections). These formulations were designed to support fat metabolism and energy production. However, modern Lipo B products often incorporate GLP-1 compounds like semaglutide to amplify weight loss results by activating glucagon-like peptide-1 receptors in the brain and pancreas.

The mechanism works by slowing gastric emptying, increasing feelings of fullness, and reducing hunger signals. When semaglutide is added to lipotropic formulations, the combination targets both appetite suppression and metabolic support, offering a dual-action approach. Clinical studies show GLP-1 receptor agonists alone produce 15% to 22% body weight reduction over 68 weeks in patients with obesity.

Wegovy vs Compounded Semaglutide Injections: Key Differences

Wegovy is the brand-name, FDA-approved semaglutide injection manufactured by Novo Nordisk. It carries significant brand markup, often costing $1,000 to $1,500 monthly without insurance coverage. Compounded semaglutide injections from licensed 503A pharmacies contain the identical active pharmaceutical ingredient but are prepared on-demand and cost substantially less. PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, making them accessible to patients without insurance or those with high deductibles.

Both products deliver semaglutide via subcutaneous injection once weekly in doses that scale based on individual response. The therapeutic outcome—appetite reduction, weight loss, improved blood sugar control—remains equivalent between branded and compounded versions when sourced from licensed 503A compounding pharmacies. Insurance coverage differs: Wegovy may qualify for coverage under specific plans, while compounded options are HSA/FSA eligible nationwide with no membership fees.

Clinical Evidence: Weight Loss Results and Safety Profile

The STEP trials (Semaglutide Treatment Effect in People with Obesity) demonstrated that semaglutide injections produced mean weight loss of 14.9% at 1.0 mg weekly and 17.4% at 2.4 mg weekly over 68 weeks, compared to 2.6% with placebo. These outcomes held across diverse populations, with sustained results when patients continued therapy. Compounded semaglutide from licensed 503A pharmacies uses the same formulation principles, delivering equivalent clinical efficacy when dosed appropriately.

Common side effects include nausea, vomiting, constipation, and diarrhea, typically mild to moderate and declining after the first 4 to 8 weeks. Serious adverse events are rare but include pancreatitis and gallbladder complications in susceptible individuals. PlexusDx recommends baseline metabolic screening before starting any GLP-1 therapy to identify contraindications and optimize treatment safety and effectiveness.

Cost, Accessibility, and Personalization With PlexusDx

PlexusDx semaglutide injection pricing is $189/mo month-to-month (or $149/mo on the 6-month plan) across all commitment tiers with flat pricing — your dose may go up, but your price won't—reflecting the company's commitment that 'your dose may need to go up, your price won't.' This transparency contrasts sharply with brand-name alternatives and supports consistent, long-term adherence. All medications ship nationwide to all 50 states, require no insurance, and accept HSA/FSA contributions for additional savings.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

When to Choose Semaglutide Injection Over Other Formats

Injectable semaglutide delivers faster absorption and more stable blood levels compared to oral tablets, resulting in stronger appetite suppression and more predictable weight loss. If you have difficulty swallowing pills, prefer once-weekly dosing, or need rapid results, injections offer clear advantages. PlexusDx also offers oral semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan) and the GLP-Squared dual-compound injection (combining semaglutide and tirzepatide) for patients who benefit from different delivery methods or enhanced metabolic targeting.

Your choice should align with lifestyle, medical history, and genetic predisposition. The PlexusDx clinical team reviews your metabolic panel, family history, and genetic test results to recommend whether semaglutide alone, tirzepatide, or a dual-compound approach best matches your physiology. This individualized matching reduces side effects, improves adherence, and maximizes sustainable weight loss outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as brand-name Wegovy?

Yes, when sourced from licensed 503A compounding pharmacies, compounded semaglutide delivers identical active pharmaceutical ingredient and clinical outcomes. PlexusDx semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), offering the same GLP-1 mechanism as Wegovy at a fraction of the cost, with nationwide shipping and no insurance requirement.

How much weight can I expect to lose with semaglutide injection?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What makes PlexusDx semaglutide more affordable than Wegovy?

PlexusDx uses licensed 503A compounding pharmacies, eliminating brand manufacturing and distribution markups that add $1,000+ monthly to Wegovy. Your dose may increase over time, but your price remains $149 monthly. HSA/FSA eligibility and no membership fees further reduce out-of-pocket costs.

Are there serious side effects I should know about with semaglutide?

Most side effects—nausea, constipation, diarrhea—are mild and decrease after 4 to 8 weeks. Rare serious effects include pancreatitis and gallbladder issues, primarily in individuals with personal or family history. PlexusDx requires baseline metabolic screening before starting therapy to identify contraindications and ensure safe, effective treatment.

How does the PlexusDx Precision Peptide Genetic Test help my treatment?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.